ResearcherFred and Pamela Buffett Cancer CenterNo recent work listed
Poomy Pandey
Matched on OpenAlex author ID A5016355312. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 22
2012: 1 paper · 2013: none · 2014: none · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper
Papers 3
- Amyloid Precursor-like Protein 2 Expression Increases during Pancreatic Cancer Development and Shortens the Survival of a Spontaneous Mouse Model of Pancreatic… Co-author DOI 10.3390/cancers13071535↗
- Amyloid precursor-like protein 2 (APLP2) affects the actin cytoskeleton and increases pancreatic cancer growth and metastasis. Co-author DOI 10.18632/oncotarget.2990↗
- Graviola: a novel promising natural-derived drug that inhibits tumorigenicity and metastasis of pancreatic cancer cells in vitro and in vivo through altering c… Co-author DOI 10.1016/j.canlet.2012.03.031↗
Closest collaborators
The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Surinder K. Batra · 3 shared papers, 2012–2021 · strength 0.18
- Paper Amyloid Precursor-like Protein 2 Expression Increases during Pancreatic Cancer Development and Shortens the Survival of… DOI 10.3390/cancers13071535↗
- Paper Amyloid precursor-like protein 2 (APLP2) affects the actin cytoskeleton and increases pancreatic cancer growth and meta… DOI 10.18632/oncotarget.2990↗
- Paper Graviola: a novel promising natural-derived drug that inhibits tumorigenicity and metastasis of pancreatic cancer cells… DOI 10.1016/j.canlet.2012.03.031↗
- Satyanarayana Rachagani · 3 shared papers, 2012–2021 · strength 0.18
- Paper Amyloid Precursor-like Protein 2 Expression Increases during Pancreatic Cancer Development and Shortens the Survival of… DOI 10.3390/cancers13071535↗
- Paper Amyloid precursor-like protein 2 (APLP2) affects the actin cytoskeleton and increases pancreatic cancer growth and meta… DOI 10.18632/oncotarget.2990↗
- Paper Graviola: a novel promising natural-derived drug that inhibits tumorigenicity and metastasis of pancreatic cancer cells… DOI 10.1016/j.canlet.2012.03.031↗
- Parthasarathy Seshacharyulu · 2 shared papers, 2015–2021 · strength 0.15
- Paper Amyloid Precursor-like Protein 2 Expression Increases during Pancreatic Cancer Development and Shortens the Survival of… DOI 10.3390/cancers13071535↗
- Paper Amyloid precursor-like protein 2 (APLP2) affects the actin cytoskeleton and increases pancreatic cancer growth and meta… DOI 10.18632/oncotarget.2990↗
- Joyce C. Solheim · 2 shared papers, 2015–2021 · strength 0.15
- Paper Amyloid Precursor-like Protein 2 Expression Increases during Pancreatic Cancer Development and Shortens the Survival of… DOI 10.3390/cancers13071535↗
- Paper Amyloid precursor-like protein 2 (APLP2) affects the actin cytoskeleton and increases pancreatic cancer growth and meta… DOI 10.18632/oncotarget.2990↗
- Shelby M. Knoche · 1 shared paper, 2021 · strength 0.11
- Brittany J. Poelaert · 1 shared paper, 2021 · strength 0.11
- Alaina C. Larson · 1 shared paper, 2021 · strength 0.11
- H. Carlo Maurer · 1 shared paper, 2021 · strength 0.11
- Kenneth P. Olive · 1 shared paper, 2021 · strength 0.11
- Richard G. MacDonald · 1 shared paper, 2015 · strength 0.04
- Jane L. Meza · 1 shared paper, 2015 · strength 0.04
- Haley L. Peters · 1 shared paper, 2015 · strength 0.04
- Srustidhar Das · 1 shared paper, 2015 · strength 0.04
- Dhanya Haridas · 1 shared paper, 2015 · strength 0.04
- Michael Anthony Hollingsworth · 1 shared paper, 2015 · strength 0.04
- Sukhwinder Kaur · 1 shared paper, 2015 · strength 0.04
- Prakash Radhakrishnan · 1 shared paper, 2015 · strength 0.04
- María P. Torres · 1 shared paper, 2012 · strength 0.03
- Vinee Purohit · 1 shared paper, 2012 · strength 0.03
- Suhasini Joshi · 1 shared paper, 2012 · strength 0.03
- Apar Kishor Ganti · 1 shared paper, 2012 · strength 0.03
- Pankaj Kumar Singh · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.